Literature DB >> 7464861

Reduction of liver blood flow and propranolol metabolism by cimetidine.

J Feely, G R Wilkinson, A J Wood.   

Abstract

We studied the influence of cimetidine on liver blood flow in eight normal subjects. Cimetidine acutely reduced liver blood flow during fasting by almost 25 per cent, as measured by indocyanine green clearance. Chronic cimetidine therapy (300 mg four times daily for seven days) reduced the flow by 33 per cent, as measured over eight hours by calculating the relative disposition of oral and intravenous propranolol. In addition to reducing the clearance of intravenous propranolol by decreasing live blood flow, cimetidine also inhibited the metabolism of oral propranolol and thereby further reduced elimination. The reduction in clearance of oral propranolol correlated positively (r = 0.87, P less than 0.05) with the average steady-state concentration of plasma cimetidine, suggesting that the inhibition of drug metabolism by cimetidine is dose related. Pulse rates at rest were markedly lower after propranolol plus cimetidine than after propranolol alone. The reduction in liver blood flow produced by cimetidine has important therapeutic implications for patients with alterations in liver and gastrointestinal blood flow and when drugs are used whose hepatic elimination depends on liver blood flow.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7464861     DOI: 10.1056/NEJM198103193041202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  121 in total

1.  Placental transfer and effects of famotidine on neonates.

Authors:  H Doi; H Maruta; I Kudoh; Y Takahashi; O Takano; K Ogawa; K Satoh; Y Okutsu
Journal:  J Anesth       Date:  1991-07       Impact factor: 2.078

2.  Emergency laparotomy in uncontrolled thyrotoxic patient with preoperative fulminant hepatic failure.

Authors:  S Kiyama; T Yoshikawa; H Ozawa; H Koh; H Maki; K Tsuzaki; K Fukushima
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

3.  Impact of ignoring extraction ratio when predicting drug-drug interactions, fraction metabolized, and intestinal first-pass contribution.

Authors:  Brian J Kirby; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2010-08-19       Impact factor: 3.922

Review 4.  Pharmacokinetic optimisation of therapy with beta-adrenergic blocking agents.

Authors:  W H Frishman; E J Lazar; G Gorodokin
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

Review 5.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

6.  The role of H2 receptor antagonist premedication in pregnant day care patients.

Authors:  J G Stock; A D Sutherland
Journal:  Can Anaesth Soc J       Date:  1985-09

7.  Effect of cimetidine premedication on morphine-induced ventilatory depression.

Authors:  A M Lam; J L Clement
Journal:  Can Anaesth Soc J       Date:  1984-01

8.  The effect of ranitidine on the disposition of lignocaine.

Authors:  R A Robson; L M Wing; J O Miners; K J Lillywhite; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

9.  The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.

Authors:  J J Houtzagers; O Streurman; C G Regårdh
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

10.  The effect of ranitidine and cimetidine on imipramine disposition.

Authors:  B G Wells; J A Pieper; T H Self; C F Stewart; S L Waldon; L Bobo; C Warner
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.